DiscoverNewsRamp Science, Exploration and Discovery PodcastPromising Results of Baxdrostat in Managing High Blood Pressure and Kidney Disease
Promising Results of Baxdrostat in Managing High Blood Pressure and Kidney Disease

Promising Results of Baxdrostat in Managing High Blood Pressure and Kidney Disease

Update: 2025-09-06
Share

Description

The FigHTN Phase 2 clinical trial revealed that baxdrostat, an aldosterone production inhibitor, reduced systolic blood pressure by 5% and decreased urine albumin loss by 55% in individuals with chronic kidney disease and uncontrolled hypertension. These findings suggest baxdrostat's potential to delay kidney disease progression and improve long-term health outcomes, offering a promising solution for this at-risk population.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Promising Results of Baxdrostat in Managing High Blood Pressure and Kidney Disease

Promising Results of Baxdrostat in Managing High Blood Pressure and Kidney Disease

NewsRamp